1
|
Bryan SJ, Lee J, Gunu R, Jones A, Olaitan A, Rosenthal AN, Cutts RJ, Garcia-Murillas I, Turner N, Lalondrelle S, Bhide SA. Circulating HPV DNA as a Biomarker for Pre-Invasive and Early Invasive Cervical Cancer: A Feasibility Study. Cancers (Basel) 2023; 15:cancers15092590. [PMID: 37174056 PMCID: PMC10177194 DOI: 10.3390/cancers15092590] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2023] [Revised: 03/29/2023] [Accepted: 04/24/2023] [Indexed: 05/15/2023] Open
Abstract
BACKGROUND High-risk HPV infection is responsible for >99% of cervix cancers (CC). In persistent infections that lead to cancer, the tumour breaches the basement membrane, releasing HPV-DNA into the bloodstream (cHPV-DNA). A next-generation sequencing assay (NGS) for detection of plasma HPV circulating DNA (cHPV-DNA) has demonstrated high sensitivity and specificity in patients with locally advanced cervix cancers. We hypothesised that cHPV-DNA is detectable in early invasive cervical cancers but not in pre-invasive lesions (CIN). METHODS Blood samples were collected from patients with CIN (n = 52) and FIGO stage 1A-1B CC (n = 12) prior to treatment and at follow-up. DNA extraction from plasma, followed by NGS, was used for the detection of cHPV-DNA. RESULTS None of the patients with pre-invasive lesions were positive for CHPV-DNA. In invasive tumours, plasma from one patient (10%) reached the threshold of positivity for cHPV-DNA in plasma. CONCLUSION Low detection of cHPV-DNA in early CC may be explained by small tumour size, poorer access to lymphatics and circulation, and therefore little shedding of cHPV-DNA in plasma at detectable levels. The detection rate of cHPV-DNA in patients with early invasive cervix cancer using even the most sensitive of currently available technologies lacks adequate sensitivity for clinical utility.
Collapse
Affiliation(s)
- Stacey J Bryan
- UCL Elizabeth Garrett Anderson Institute for Women's Health, Faculty of Population Health Sciences, University College London, Medical School Building, 74 Huntley Street, London WC1E 6AU, UK
| | - Jen Lee
- The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK
- The Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK
| | - Richard Gunu
- Translational Research Lab, Department of Women's Cancer, IfWH, Ground Floor POGB, 72 Huntley Street, London WC1E 6DD, UK
| | - Allison Jones
- Translational Research Lab, Department of Women's Cancer, IfWH, Ground Floor POGB, 72 Huntley Street, London WC1E 6DD, UK
| | - Adeola Olaitan
- UCL Elizabeth Garrett Anderson Institute for Women's Health, Faculty of Population Health Sciences, University College London, Medical School Building, 74 Huntley Street, London WC1E 6AU, UK
| | - Adam N Rosenthal
- UCL Elizabeth Garrett Anderson Institute for Women's Health, Faculty of Population Health Sciences, University College London, Medical School Building, 74 Huntley Street, London WC1E 6AU, UK
| | - Ros J Cutts
- The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK
- The Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK
| | - Isaac Garcia-Murillas
- The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK
- The Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK
| | - Nick Turner
- The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK
- The Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK
| | | | - Shreerang A Bhide
- The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK
- The Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK
| |
Collapse
|
2
|
Turner NC, Garcia-Murillas I, Chopra N, Beaney M, Cutts RJ, Swift C, Kriplani D, Morden J, Hrebien S, Comino-Mendez I, Afentakis M, Bliss J, Skene A, Wheatley D, Russell S, Evans A, Dowsett M, Smith IE. Abstract P2-02-01: Withdrawn. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p2-02-01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
This abstract was withdrawn by the authors.
Collapse
Affiliation(s)
- NC Turner
- Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital, London, United Kingdom; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, United Kingdom; Royal Bournemouth Hospital, Bournemouth, United Kingdom; Royal Cornwall Hospital, Truro, United Kingdom; Hichingbrooke Hospital, Hungtindon, United Kingdom; Poole Hospital, Poole, United Kingdom
| | - I Garcia-Murillas
- Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital, London, United Kingdom; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, United Kingdom; Royal Bournemouth Hospital, Bournemouth, United Kingdom; Royal Cornwall Hospital, Truro, United Kingdom; Hichingbrooke Hospital, Hungtindon, United Kingdom; Poole Hospital, Poole, United Kingdom
| | - N Chopra
- Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital, London, United Kingdom; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, United Kingdom; Royal Bournemouth Hospital, Bournemouth, United Kingdom; Royal Cornwall Hospital, Truro, United Kingdom; Hichingbrooke Hospital, Hungtindon, United Kingdom; Poole Hospital, Poole, United Kingdom
| | - M Beaney
- Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital, London, United Kingdom; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, United Kingdom; Royal Bournemouth Hospital, Bournemouth, United Kingdom; Royal Cornwall Hospital, Truro, United Kingdom; Hichingbrooke Hospital, Hungtindon, United Kingdom; Poole Hospital, Poole, United Kingdom
| | - RJ Cutts
- Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital, London, United Kingdom; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, United Kingdom; Royal Bournemouth Hospital, Bournemouth, United Kingdom; Royal Cornwall Hospital, Truro, United Kingdom; Hichingbrooke Hospital, Hungtindon, United Kingdom; Poole Hospital, Poole, United Kingdom
| | - C Swift
- Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital, London, United Kingdom; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, United Kingdom; Royal Bournemouth Hospital, Bournemouth, United Kingdom; Royal Cornwall Hospital, Truro, United Kingdom; Hichingbrooke Hospital, Hungtindon, United Kingdom; Poole Hospital, Poole, United Kingdom
| | - D Kriplani
- Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital, London, United Kingdom; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, United Kingdom; Royal Bournemouth Hospital, Bournemouth, United Kingdom; Royal Cornwall Hospital, Truro, United Kingdom; Hichingbrooke Hospital, Hungtindon, United Kingdom; Poole Hospital, Poole, United Kingdom
| | - J Morden
- Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital, London, United Kingdom; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, United Kingdom; Royal Bournemouth Hospital, Bournemouth, United Kingdom; Royal Cornwall Hospital, Truro, United Kingdom; Hichingbrooke Hospital, Hungtindon, United Kingdom; Poole Hospital, Poole, United Kingdom
| | - S Hrebien
- Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital, London, United Kingdom; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, United Kingdom; Royal Bournemouth Hospital, Bournemouth, United Kingdom; Royal Cornwall Hospital, Truro, United Kingdom; Hichingbrooke Hospital, Hungtindon, United Kingdom; Poole Hospital, Poole, United Kingdom
| | - I Comino-Mendez
- Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital, London, United Kingdom; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, United Kingdom; Royal Bournemouth Hospital, Bournemouth, United Kingdom; Royal Cornwall Hospital, Truro, United Kingdom; Hichingbrooke Hospital, Hungtindon, United Kingdom; Poole Hospital, Poole, United Kingdom
| | - M Afentakis
- Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital, London, United Kingdom; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, United Kingdom; Royal Bournemouth Hospital, Bournemouth, United Kingdom; Royal Cornwall Hospital, Truro, United Kingdom; Hichingbrooke Hospital, Hungtindon, United Kingdom; Poole Hospital, Poole, United Kingdom
| | - J Bliss
- Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital, London, United Kingdom; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, United Kingdom; Royal Bournemouth Hospital, Bournemouth, United Kingdom; Royal Cornwall Hospital, Truro, United Kingdom; Hichingbrooke Hospital, Hungtindon, United Kingdom; Poole Hospital, Poole, United Kingdom
| | - A Skene
- Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital, London, United Kingdom; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, United Kingdom; Royal Bournemouth Hospital, Bournemouth, United Kingdom; Royal Cornwall Hospital, Truro, United Kingdom; Hichingbrooke Hospital, Hungtindon, United Kingdom; Poole Hospital, Poole, United Kingdom
| | - D Wheatley
- Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital, London, United Kingdom; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, United Kingdom; Royal Bournemouth Hospital, Bournemouth, United Kingdom; Royal Cornwall Hospital, Truro, United Kingdom; Hichingbrooke Hospital, Hungtindon, United Kingdom; Poole Hospital, Poole, United Kingdom
| | - S Russell
- Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital, London, United Kingdom; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, United Kingdom; Royal Bournemouth Hospital, Bournemouth, United Kingdom; Royal Cornwall Hospital, Truro, United Kingdom; Hichingbrooke Hospital, Hungtindon, United Kingdom; Poole Hospital, Poole, United Kingdom
| | - A Evans
- Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital, London, United Kingdom; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, United Kingdom; Royal Bournemouth Hospital, Bournemouth, United Kingdom; Royal Cornwall Hospital, Truro, United Kingdom; Hichingbrooke Hospital, Hungtindon, United Kingdom; Poole Hospital, Poole, United Kingdom
| | - M Dowsett
- Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital, London, United Kingdom; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, United Kingdom; Royal Bournemouth Hospital, Bournemouth, United Kingdom; Royal Cornwall Hospital, Truro, United Kingdom; Hichingbrooke Hospital, Hungtindon, United Kingdom; Poole Hospital, Poole, United Kingdom
| | - IE Smith
- Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital, London, United Kingdom; Clinical Trials & Statistics Unit, The Institute of Cancer Research, London, United Kingdom; Royal Bournemouth Hospital, Bournemouth, United Kingdom; Royal Cornwall Hospital, Truro, United Kingdom; Hichingbrooke Hospital, Hungtindon, United Kingdom; Poole Hospital, Poole, United Kingdom
| |
Collapse
|